Medicine
Metoprolol 25 mg extended-release tablet
Metoprolol 25 mg extended-release tablet is a generic prescription medicine for oral use, made by 32 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Metoprolol
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 157 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaZydus LifesciencesIndiaAscend LaboratoriesIndiaGranules IndiaIndiaCamber PharmaceuticalsIndiaOryza PharmaceuticalsCranbury PharmaceuticalsActavis PharmaEpic Pharma32 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 September 2012
- Identifiers
- RxCUI 866412, 866419, 866427 +1DailyMed set ID 74a28333-53c1-493e-b6ad-2192fdc35391, 71b27b55-44aa-113d-e053-2995a90a1cf7, 5a65a60c-4c0d-e89b-e063-6394a90ac689 +37NDC 31722-589, 50268-540, 67296-2325 +37Application ANDA205541, ANDA090617, ANDA203894 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 32 labelers. The register lists 160 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated, extended release in 1 bottle | 55111-466-01 | Dr. Reddy's LaboratoriesIndia | 10 September 2012 |
| 500 tablet, film coated, extended release in 1 bottle | 55111-466-05 | Dr. Reddy's LaboratoriesIndia | 10 September 2012 |
| 30 tablet, film coated, extended release in 1 bottle | 55111-466-30 | Dr. Reddy's LaboratoriesIndia | 10 September 2012 |
| 60 tablet, film coated, extended release in 1 bottle | 55111-466-60 | Dr. Reddy's LaboratoriesIndia | 10 September 2012 |
| 10 blister pack in 1 carton / 10 tablet, film coated, extended release in 1 blister pack | 55111-466-78 | Dr. Reddy's LaboratoriesIndia | 10 September 2012 |
| 100 tablet, film coated, extended release in 1 bottle | 75907-344-01 | Dr. Reddy's LaboratoriesIndia | 13 January 2026 |
| 1000 tablet, film coated, extended release in 1 bottle | 75907-344-10 | Dr. Reddy's LaboratoriesIndia | 13 January 2026 |
| 1000 tablet, extended release in 1 bottle | 62207-130-49 | Granules IndiaIndia | 1 August 2025 |
| 30 tablet, extended release in 1 bottle | 62207-130-54 | Granules IndiaIndia | 1 August 2025 |
| 100 tablet, film coated, extended release in 1 bottle | 70010-780-01 | Granules IndiaIndia | 2 October 2023 |
| 500 tablet, film coated, extended release in 1 bottle | 70010-780-05 | Granules IndiaIndia | 2 October 2023 |
| 1000 tablet, film coated, extended release in 1 bottle | 70010-780-10 | Granules IndiaIndia | 2 October 2023 |
| 100 tablet, extended release in 1 bottle | 68382-564-01 | Zydus LifesciencesIndia | 7 June 2018 |
| 500 tablet, extended release in 1 bottle | 68382-564-05 | Zydus LifesciencesIndia | 7 June 2018 |
| 1000 tablet, extended release in 1 bottle | 68382-564-10 | Zydus LifesciencesIndia | 7 June 2018 |
| 1000 tablet, extended release in 1 bottle | 70771-1338-0 | Zydus LifesciencesIndia | 7 June 2018 |
| 100 tablet, extended release in 1 bottle | 70771-1338-1 | Zydus LifesciencesIndia | 7 June 2018 |
| 500 tablet, extended release in 1 bottle | 70771-1338-5 | Zydus LifesciencesIndia | 7 June 2018 |
| 100 tablet, film coated, extended release in 1 bottle | 67877-590-01 | Ascend LaboratoriesIndia | 27 November 2020 |
| 500 tablet, film coated, extended release in 1 bottle | 67877-590-05 | Ascend LaboratoriesIndia | 27 November 2020 |
| 1000 tablet, film coated, extended release in 1 bottle | 67877-590-10 | Ascend LaboratoriesIndia | 27 November 2020 |
| 30 tablet, film coated, extended release in 1 bottle | 67877-590-30 | Ascend LaboratoriesIndia | 27 November 2020 |
| 60 tablet, film coated, extended release in 1 bottle | 67877-590-60 | Ascend LaboratoriesIndia | 27 November 2020 |
| 100 tablet, film coated, extended release in 1 bottle | 31722-589-01 | Camber PharmaceuticalsIndia | 6 November 2020 |
| 500 tablet, film coated, extended release in 1 bottle | 31722-589-05 | Camber PharmaceuticalsIndia | 23 April 2021 |
| 1000 tablet, film coated, extended release in 1 bottle | 31722-589-10 | Camber PharmaceuticalsIndia | 23 April 2021 |
| 30 tablet, film coated, extended release in 1 bottle | 31722-589-30 | Camber PharmaceuticalsIndia | 6 November 2020 |
| 100 tablet, extended release in 1 package | 72516-025-01 | Oryza pharmaceuticals | 15 May 2026 |
| 1000 tablet, extended release in 1 package | 72516-025-10 | Oryza pharmaceuticals | 15 May 2026 |
| 500 tablet, extended release in 1 package | 72516-025-50 | Oryza pharmaceuticals | 15 May 2026 |
| 100 tablet, extended release in 1 bottle | 72516-030-01 | Oryza Pharmaceuticals | 27 April 2022 |
| 1000 tablet, extended release in 1 bottle | 72516-030-10 | Oryza Pharmaceuticals | 27 April 2022 |
| 500 tablet, extended release in 1 bottle | 72516-030-50 | Oryza Pharmaceuticals | 27 April 2022 |
| 100 tablet, film coated, extended release in 1 bottle | 45963-709-11 | Actavis Pharma | 23 October 2019 |
| 1000 tablet, film coated, extended release in 1 bottle | 45963-709-96 | Actavis Pharma | 23 October 2019 |
| 100 tablet, extended release in 1 bottle | 27808-302-01 | Cranbury Pharmaceuticals | 1 June 2025 |
| 500 tablet, extended release in 1 bottle | 27808-302-02 | Cranbury Pharmaceuticals | 1 June 2025 |
| 1000 tablet, extended release in 1 bottle | 27808-302-03 | Cranbury Pharmaceuticals | 1 June 2025 |
| 100 tablet, extended release in 1 bottle | 42806-724-01 | Epic Pharma | 1 February 2025 |
| 500 tablet, extended release in 1 bottle | 42806-724-05 | Epic Pharma | 1 February 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 August 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Metoprolol 25 mg extended-release tablet.
Other strengths and forms of Metoprolol
Clinical summary
Metoprolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as extended-release tablets, tablets and injection for oral and intravenous use. MedsAcross supplies Metoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetoprololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lopressor prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Metoprolol 25 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.